<html xml:lang="en-us" lang="en-us" xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops"><head>
    <link rel="stylesheet" type="text/css" href="../../../../css/base.css" />
<link rel="stylesheet" type="text/css" href="../../../../css/kotobeeInteractive.css" />
<link rel="stylesheet" type="text/css" href="../../../../css/global.css" />
<link rel="stylesheet" type="text/css" href="../css/base.css" />
<link rel="stylesheet" type="text/css" href="../css/global.css" />
<link rel="stylesheet" type="text/css" href="../css/kotobeeInteractive.css" />

    <script type="text/javascript" src="../../../../js/kotobeeInteractive.js"></script>
<script type="text/javascript" src="../../../../js/global.js"></script>
<script type="text/javascript" src="../js/kotobeeInteractive.js"></script>
<script type="text/javascript" src="../js/global.js"></script>

    <title>Agitated delirium</title>
    

<meta name="m-checksum" content="678931663" />
<meta charset="utf-8" />
 <meta name="kotobee-chapter" content="epubypzqs\EPUB\xhtml\sxb8vx.xhtml" />
<meta name="kotobee-book" content="urn:uuid:135eddec-c62b-c901-75df-e60eca42e580" />
</head>
<body>
<p>Agitated delirium is common in advanced illnesses. It is a bad prognostic marker in patients with advanced cancer and, if not caused by an easily reversible aetiology, it may indicate that the patient is entering the last few weeks of life.</p>

<p>Consider the underlying causes and treat these if appropriate and possible.</p>

<table>
	<tbody>
		<tr>
			<td><strong>Cause</strong></td>
			<td><strong>Possible treatment</strong></td>
		</tr>
		<tr>
			<td><a class="link358" href="s7xbgo.xhtml">Hypercalcaemia</a></td>
			<td>
			<p>Bisphosphonate&#160;</p>

			<p>IV or subcut&#160;fluids</p>
			</td>
		</tr>
		<tr>
			<td>Hyponatraemia (due to SIADH)</td>
			<td>
			<p>Fluid restriction</p>

			<p>Salt tablets</p>

			<p>Demeclocycline <sup><em>(special access scheme)</em></sup></p>
			</td>
		</tr>
		<tr>
			<td><a class="link977" href="st608h.xhtml">Cerebral primary or metastases</a></td>
			<td>Increase dexamethasone dose</td>
		</tr>
		<tr>
			<td>Medications (e.g. dexamethasone, morphine)</td>
			<td>Reduce dose or change to an alternative</td>
		</tr>
		<tr>
			<td>Infection (e.g. UTI)</td>
			<td>Antibiotics</td>
		</tr>
		<tr>
			<td>Hepatic encephalopathy</td>
			<td>
			<p>Lactulose</p>

			<p>Rifaximin <sup><em>(PBS authority)</em></sup></p>
			</td>
		</tr>
		<tr>
			<td>Dehydation</td>
			<td>Rehydrate</td>
		</tr>
	</tbody>
</table>

<p>&#160;</p>

<p>Non-pharmacological measures such as reassurance, orientation and lighting, close contact by loved ones and a quiet environment are very important.</p>

<p>Short-term low-dose antipsychotics may reduce distressing symptoms but may not improve outcomes (e.g. the likelihood of returning to live independently). Haloperidol is often a good first-line option. The following doses are low and may require titration up:</p>

<ul>
	<li>Haloperidol 0.5mg at night orally or subcut<br />
	AND<br />
	Haloperidol 0.5mg PRN three times daily orally or subcut</li>
</ul>

<p>If sleep disturbance is a prominent problem, quetiapine <em><sup>(non-PBS indication)</sup> </em>or olanzapine <em><sup>(non-PBS indication)</sup></em> may be preferred to haloperidol</p>

<p>If anxiety is playing a large role, adding a benzodiazepine may be appropriate</p>

<p>Consider seeking a geriatrics opinion for advice</p>


</body></html>